Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bleb

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Bleb in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, R; Barr, RM; Courtney, P; Greaves, MW; Judge, MR; Kobza Black, A; Lawlor, F; Mallet, AI1
Barber, LA; Clay, KL; Hood, AF; Johnson, CA; Morelli, JG; Morin, SM; Murphy, RC; Pei, Y; Travers, JB; Williams, DA1
Eriksson, EE; Hedqvist, P; Johansson, J; Lindbom, L; Ruoslahti, E; Werr, J1
Hachisuka, H; Karashima, T; Okubo, K; Sasai, Y1
Chesterman, CN; Earl, JW; Kemp, A; Krilis, SA; Macpherson, JL; Mallet, AI; Rogers, M; Spur, B; Toia, RF1

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bleb

ArticleYear
Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
    British journal of clinical pharmacology, 1993, Volume: 35, Issue:6

    Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Arachidonic Acid; Blister; Clobetasol; Dinoprostone; Exudates and Transudates; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipid Metabolism; Male; Middle Aged; Platelet Activating Factor; Skin

1993
Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases.
    Prostaglandins & other lipid mediators, 1998, Volume: 56, Issue:5-6

    Topics: Animals; Binding, Competitive; Blister; Blotting, Northern; Calcimycin; Calcium; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycerylphosphorylcholine; Humans; Inflammation; KB Cells; Pemphigoid, Bullous; Phosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Wistar; Retroviridae; Time Factors; Transduction, Genetic

1998
Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: Adult; Animals; Antibodies, Monoclonal; Blister; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Collagen; Gelatin; Gels; Humans; Inflammation; Integrin beta1; Integrins; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Video; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritoneal Cavity; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Collagen

2000
The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
    The Kurume medical journal, 1989, Volume: 36, Issue:4

    Topics: Adult; Aged; Biological Assay; Blister; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Platelet Activating Factor; Platelet Aggregation; Skin Diseases, Vesiculobullous

1989
Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis.
    Clinical and experimental immunology, 1989, Volume: 77, Issue:3

    Topics: Blister; Humans; Infant, Newborn; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Urticaria Pigmentosa

1989